EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY

Egyptian International Pharmaceutical Industries Company

PHAR

EGS38081C013

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
35.97 ^EGP	+2.77%		-13.97%	-1.45%

Mar. 01	Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 05	Egyptian International Pharmaceutical Industries Company(CASE:PHAR) added to EGX 30 Index	CI

Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2021

February 23, 2022 at 03:08 am EST

Egyptian International Pharmaceutical Industries Company reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EGP 3,436.98 million compared to EGP 2,885.63 million a year ago. Net income was EGP 522.27 million compared to EGP 486.51 million a year ago.

Latest news about Egyptian International Pharmaceutical Industries Company

Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 01	CI
Egyptian International Pharmaceutical Industries Company(CASE:PHAR) added to EGX 30 Index	Feb. 04	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 14	CI
Medical Union Pharmaceuticals Company announced that it expects to receive funding from Egyptian International Pharmaceutical Industries Company and other investors	23-09-17	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-23	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-05	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-10	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-25	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Nine Months Ended September 30, 2021	21-11-07	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-11	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-11	CI
Egyptian International Pharmaceutical Industries Approves Cash Dividend for 2020	21-03-28	CI
Egyptian International Pharmaceutical Industries Company Appoints Ahmed Saeed Mohamed Kilany as the Company's Chairman and Managing Director	21-03-28	CI
Egyptian International Pharmaceutical Industries Company's Equity Buyback announced on March 29, 2020, has expired.	21-03-27	CI
Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-25	CI
Medical Union Pharmaceuticals Company announced that it expects to receive EGP 74.82 million in funding from Egyptian International Pharmaceutical Industries Company	20-12-26	CI
Egyptian International Pharmaceutical Industries Company Declares Cash Dividends; Reports Earnings Results for the Year 2019	20-03-29	CI
Egyptian International Pharmaceutical Industries Company announces an Equity Buyback for 1.61% of its issued share capital.	20-03-29	CI
Egyptian International Pharmaceutical Industries Company authorizes a Buyback Plan.	20-03-28	CI
Egyptian International Pharmaceutical Industries Company completed the acquisition of 9.8% stake of Medical Union Pharmaceuticals Company from Egy Lease approximately EGP 210 million.	19-12-21	CI
Egyptian International Pharmaceuticals Reports Consolidated Earnings Results for the Six Months Ended June 30, 2019	19-08-14	CI
Egyptian International Pharmaceuticals Reports Standalone Earnings Results for the Six Months Ended June 30, 2019	19-08-14	CI
Egyptian International Pharmaceutical Industries Company agreed to acquire 9.8% stake of Medical Union Pharmaceuticals Company from Egy Lease.	19-06-25	CI
Egyptian International Pharmaceutical Industries Company Reports Consolidated and Standalone Earnings Results for the First Quarter Ended March 31, 2019	19-05-14	CI

Chart Egyptian International Pharmaceutical Industries Company

Duration

Period

Chart Egyptian International Pharmaceutical Industries Company

More charts

Company Profile

Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) specializes in manufacturing and marketing pharmaceutical products. The products include primarily antibiotics, vitamins, anesthetics and analgesics, drugs for eye care, treatment of rheumatism, gout, gastrointestinal, dermatological and cardiovascular diseases, and are administered as capsules, gels and effervescent tablets.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for Egyptian International Pharmaceutical Industries Company

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

35.97 EGP

Average target price

75.3 EGP

Spread / Average Target

+109.34%

Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES COMPANY	-1.45%	112M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.98%	43.67B
OTSUKA HOLDINGS CO., LTD.	+20.67%	22.51B
SANDOZ GROUP AG	+14.26%	14.6B
CIPLA LIMITED	+14.32%	13.74B
ZYDUS LIFESCIENCES LIMITED	+44.72%	11.91B
ONO PHARMACEUTICAL CO., LTD.	-8.37%	7.04B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.42B

Generic Pharmaceuticals